We are live on ! Find out more
ADVM

Adverum Biotechnologies

Delisted

ADVM was delisted on the 8th of December, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCM
1
BML Capital Management
Indiana
$15.9M +$2.19M +302,064 +15%
TCM
2
TCG Crossover Management
California
$14.1M -$7 -1 -0%
Franklin Resources
3
Franklin Resources
California
$13.6M +$29 +4 +0%
BlackRock
4
BlackRock
New York
$10.5M +$590K +81,268 +6%
VA
5
VR Adviser
New York
$10.3M
FLSM
6
Frazier Life Sciences Management
California
$7.51M
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.21M +$132K +18,195 +2%
VC
8
Vivo Capital
California
$5.85M
5VM
9
5AM Venture Management
California
$3.8M
VVM
10
Versant Venture Management
California
$3.56M
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.08M -$121K -16,731 -4%
Goldman Sachs
12
Goldman Sachs
New York
$2.98M +$197K +27,156 +7%
LGM
13
Logos Global Management
California
$2.92M
State Street
14
State Street
Massachusetts
$2.59M +$662K +91,112 +33%
PFCS
15
Pale Fire Capital SE
Czech Republic
$2.16M +$2.24M +308,371 New
SCM
16
Soleus Capital Management
Connecticut
$2.02M +$1.02M +140,000 +95%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$1.65M -$2.92M -402,791 -63%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$1.45M -$121K -16,684 -7%
Nuveen
19
Nuveen
North Carolina
$1.22M +$763K +105,140 +153%
Northern Trust
20
Northern Trust
Illinois
$1.09M +$783K +107,834 +229%
Morgan Stanley
21
Morgan Stanley
New York
$626K -$291K -40,076 -31%
AQR Capital Management
22
AQR Capital Management
Connecticut
$421K +$435K +59,970 New
Charles Schwab
23
Charles Schwab
California
$419K
Squarepoint
24
Squarepoint
New York
$350K -$429K -59,134 -54%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$339K -$118K -16,250 -25%